Evidence map›Paper›PMID 36534404›Full record

ArticleJAMA network open2022

Assessment of COVID-19 Incidence and Severity Among Recipients of Allogenic Stem Cell Transplant After 1 or 2 mRNA Booster Doses During the Omicron Wave in France.

Valentin Letailleur, Amandine Le Bourgeois, Thierry Guillaume, Maxime Jullien, Marianne Coste-Burel, Marie C Béné, Patrice Chevallier

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Valentin LetailleurHematology Department, Nantes University Hospital, Nantes, France.
Amandine Le BourgeoisHematology Department, Nantes University Hospital, Nantes, France.
Thierry GuillaumeHematology Department, Nantes University Hospital, Nantes, France.
Maxime JullienHematology Department, Nantes University Hospital, Nantes, France.
Marianne Coste-BurelVirology Department, Nantes University Hospital, Nantes, France.
Marie C BénéInstitut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche UMR1232, Centre de Recherche en Cancérologie et Immunologie Nantes-Angers, Institut de Recherche en Santé de l'Université de Nantes, University of Nantes, France.
Patrice ChevallierHematology Department, Nantes University Hospital, Nantes, France.
Inserm · FRNantes Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19FranceHumansIncidence

Identifiers

PMID36534404
PMCPMC9856420
OpenAlexW4312095415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.